|
697 Chloramphenicol
eye drops approved as pharmacy medicine for treatment of bacterial conjunctivitis Chloramphenicol
0.5 per cent eye drops have been reclassified as a pharmacy medicine
...more
697 Pharmacy
guidance on CD regulations published by Society Guidance on
what pharmacists should be doing to comply with current and planned Controlled
Drugs regulations has been published by the Royal Pharmaceutical Society
...more
697 National Pharmaceutical Association’s image lacks impact The National Pharmaceutical Association’s carboy logo is old-fashioned, is not well recognised and lacks impact, a design agency told the chairman and board members at their May board meeting
...more
698 Stop-smoking
training should focus on counselling Smoking cessation training
programmes for pharmacists should focus on counselling skills, rather
than facts about smoking, research by the Health Development Agency,
in conjunction with PharmacyHealthLink, suggests ...more
698 Nicotine
myths prevent smokers from quitting Misconceptions about the
role of nicotine are preventing smokers from using nicotine replacement
therapy (NRT) when they attempt to quit, data due to be presented at
the UK National Smoking Cessation Conference in London this week suggest
...more
698 More
women than men get their blood pressure checked Twice as many
women as men are taking advantage of free health monitoring services
such as diabetes screening and blood pressure monitoring at Lloydspharmacy,
the community pharmacy chain announced this week ...more
698 Patient
knowledge of diabetes does not improve disease control, researchers say Patients
with diabetes who have a better understanding of their condition do not
necessarily have better disease control, research suggests ...more
698 Diabetes
roadshows LifeScan, a manufacturer of blood glucose monitors, will be holding a series of patient roadshows in conjunction with Diabetes UK to coincide with diabetes week (12–18 June)
...more
699 New
oxygen contract is a risk to patients, says PSNC The introduction
of new arrangements for the supply of oxygen to patients at home could
compromise patient care, according to the Pharmaceutical Services Negotiating
Committee ...more
699 Experts to
tackle violence against NHS staff Local security management
specialists will be based at every NHS hospital trust and primary care
trust by June 2006, the NHS Security Management Service announced this
week. These specialists will work in partnership with the police to investigate
assaults on staff and ensure appropriate action is taken ...more
699 NHS24 needs
to improve, independent review team says Improvements that
NHS24 should make were set out last week by an independent review team
...more
699 Floor space
exemption should exclude added mezzanines Pharmacies under
15,000 square metres should not be allowed to have mezzanines added in
order to extend their floor space and become exempt from the NHS (Pharmaceutical
Services) Regulations 2005, the Pharmaceutical Services Negotiating Committee
has said ...more
700 OTC simvastatin
response mix up The Medicines and Healthcare products Regulatory
Agency has this week admitted that only a third of the responses to the
consultation on the change of simvastatin to an over-the-counter medicine
were favourable ...more
700 Management
restructured at Boots The Chemists Commercial management of
Boots The Chemists is to be restructured, Richard Baker, chief executive
of Boots The Chemists, announced this week ...more
700 Investigation
by The Sun prompts Society action The Royal Pharmaceutical
Society has asked The Sun newspaper to share evidence that some pharmacists
allegedly unlawfully sold prescription-only medicines to an undercover
investigator without following the proper procedures for emergency supply
...more
|
701 Drug for
chemotherapy-induced nausea and vomiting launched A new single-dose
drug for the treatment of chemotherapy-induced nausea and vomiting was
launched this week by Cambridge Laboratories ...more
701 Docetaxel
increases breast cancer survival Survival among women with
operable, node-positive breast cancer is higher with adjuvant docetaxel
therapy than with adjuvant fluorouracil therapy, according to new data
...more
701 Dispensing
robots installed Three new dispensing robots have been installed
in the Ipswich Hospital NHS Trust, as part of a £1.79m programme
that includes building a new pharmacy manufacturing unit ...more
701 Daily ibuprofen
use linked to increased breast cancer risk Long-term daily
use of ibuprofen may be associated with an increased risk of breast cancer,
results of a study involving 114,000 women suggest ...more
701 Patient information
records The NHS Information Standards Board has launched a
set of standards for documenting patient information ...more
701 HPA vaccine
report The Health Protection Agency has published a report
on the current status of UK vaccine programmes ...more
701 E111 campaign A
campaign to promote use of E111 cover for European travel has been launched
by the Department of Health ...more
702 Pharmacist-led
company provides PIL user-testing A pharmacist-led University
of Leeds spin-out company, LUTO, has been set up to provide a patient
information leaflet (PIL) testing service to the pharmaceutical industry
...more
702 Google is
primary health resource for 1 in 8 Google, the internet search
engine, is the first port of call for 12 per cent of people looking for
information on illness, a survey of 1,000 consumers has found ...more
702 British Library
articles The British Library has launched a pay-as-you-go
service, giving access to the past five years of articles from the top
20,000 research journals ...more
702 UK PubMed
Central A group of major funders of science research, including
the Wellcome Trust and the Medical Research Council, is planning to set
up a free, open access, online database of peer-reviewed papers arising
from research they have funded — a UK version of the US PubMed
Central ...more
R&D News
703 Trial vaccine
reduces shingles pain in older people Older people at risk
of developing shingles (Herpes zoster) and associated neuropathic pain
may benefit from a vaccine currently under investigation, new data suggest
...more
703 Novel tyrosine
kinase inhibitor improves survival in patients with Glivec-resistant
GIST Survival in patients with gastrointestinal stromal tumours
(GIST) who had become resistant to imatinib (Glivec) was improved by
treatment with a new oral, multi-targeted tyrosine kinase inhibitor,
SU11248. Treatment also achieved response in late-stage kidney cancer
...more
703 Drug designed
for lung cancer shrinks breast tumours A drug that was originally
designed for the treatment of lung cancer may be beneficial for patients
with breast cancer, say researchers ...more
703 New drug
for skin infections A novel lipoglycopeptide antibiotic, telavancin,
has been shown to be beneficial for treating skin infections including
methicillin-resistant Staphylococcus aureus ...more
703 Gene therapy
for arthritis A therapeutic gene can be safely transferred
into human rheumatoid joints, say researchers ...more
703 Growth factor
may help Crohn’s Severity of Crohn’s disease
may be decreased by a haematopoietic growth factor ...more
|
The
Pharmaceutical Journal